News


Tom Flottman, Chief Executive Officer and Part Owner of the Flottman Company, Announces His Retire

Friday , 21 July 2017

 

Tom Flottman, for the past 15 years, has served as CEO, Spokesperson and Liaison of the Flottman Company has announced his retirement retroactive June 30th 2017

Cincinnati, Ohio - Crestview Hills, Kentucky, July 21, 2017 (GLOBE NEWSWIRE) --Tom Flottman has in some manner worked within Flottman Company for over 44 ...

READ MORE...


Global Market For Cell Therapy Manufacturing 2017

Friday , 21 July 2017

 

Dublin, July 21, 2017 (GLOBE NEWSWIRE) -- The "The Market For Cell Therapy Manufacturing - Strategies for Pricing, Cost Cont...

READ MORE...


Global Alcohol Enzymes Market Will Reach USD 3.0 Billion by 2022: Zion Market Research According

Thursday , 20 July 2017

 

According to the report, global alcohol enzyme market was valued at over USD 1.9 billion in 2016, is expected to reach above USD 3.0 billion by 2022 and is anticipated to grow at a CAGR of slightly above 7.7% between 2016 and 2022

Sarasota, FL, July 20, 2017 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Al...

READ MORE...


AXIM Biotech Enters Services Agreement With Israel-Based CRO to Begin Clinical POC Study on CBD and

Thursday , 20 July 2017

AXIM Biotech Enters Services Agreement With Israel-Based CRO to Begin Clinical POC Study on CBD and Gabapentin Chewing Gum for Treatment of Restless Leg Syndrome

NEW YORK, July 20, 2017 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC:...

READ MORE...


Avadel Pharmaceuticals to Report Second Quarter 2017 Results

Thursday , 20 July 2017

 

DUBLIN, Ireland, July 20, 2017 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ:AVDL), today announced it will report its second quarter 2017 financial results on Tuesday, August 8, 2017, before the market open. A conference call to discuss these results has been scheduled for...

READ MORE...


Veru Healthcare Announces Key Advancements in the Development of Tamsulosin DRS for Benign Prostat

Thursday , 20 July 2017

 

MIAMI, July 20, 2017 (GLOBE NEWSWIRE) -- Veru Healthcare (NASDAQ:FHCO), a biopharmaceutical company focused on urology and oncology, today announced that the company has initiated the subject screening process for Stage 2 of its bioequivalence study ...

READ MORE...


Diffusion Pharmaceuticals Achieves Drug Production Milestone For Planned Phase 3 Clinical Trial In

Thursday , 20 July 2017

 

Diffusion Pharmaceuticals Achieves Drug Production Milestone For Planned Phase 3 Clinical Trial In Inoperable GBM Brain Cancer

CHARLOTTESVILLE, Va., July 20, 2017 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), a clinical stage biotechnology company devel...

READ MORE...


Isodiol International Inc. Signs Definitive Licensing Agreement With Canopy Growth Corporation for

Thursday , 20 July 2017

 

Isodiol International Inc. Signs Definitive Licensing Agreement With Canopy Growth Corporation for Canadian and International Distribution

VANCOUVER, British Columbia, July 20, 2017 (GLOBE NEWSWIRE) -- Isodiol International Inc. (CSE:ISOL) (OTC:LAGBF) (Frankfurt:LB6A.F) (the “Compan...

READ MORE...


Global Automated Storage and Retrieval Systems Market 2017-2025 - Key Players are Bastian Solution

Thursday , 20 July 2017

 

Global Automated Storage and Retrieval Systems Market 2017-2025 - Key Players are Bastian Solutions, Daifuku, Kardex Group, SSI Schaeffer Systems and Murata machinery

Dublin, July 20, 2017 (GLOBE NEWSWIRE) -- The READ MORE...


Transforming Pharmaceutical R&D with Data: 2017 Research Explores if Current R&D Economics are Uns

Thursday , 20 July 2017

 

Dublin, July 20, 2017 (GLOBE NEWSWIRE) -- The "Transforming Pharmaceutical R&D with Data" report has been added to Research and Markets' offering. 

In the cur...

READ MORE...


Featured Employers

© 2017 Jobsinpharma - 4ward Technologies Ltd All rights reserved.